Global Durable Medical Equipment (DME) Market to Reach USD 270 Billion at 6% CAGR During 2022-2031; Growing Geriatric Population and Diverse Utility of DMEs for Improved Quality of Life to Support Growth

2022-08-13 05:34:59 By : Ms. Angela Zeng

Key Companies Covered in the Global Durable Medical Equipment (DME) Market Research Report by Kenneth Research are Stryker, NIHON KOHDEN CORPORATION, General Electric Company, GF Health Products, Inc., Medtronic, Getinge AB, Compass Health Brands, Dun & Bradstreet, Inc., Koninklijke Philips N.V., Medical Device Depot, Inc., and others.

New York, Aug. 08, 2022 (GLOBE NEWSWIRE) -- According to data from the World Health Organization, the number of geriatric population, i.e., adults 60 years of age and older, is increasing. In 2019, 1 billion people were 60 years of age or older across the globe. This number is anticipated to increase to 1.4 billion by 2030 and to 2.1 billion by 2050.

Kenneth Research has published a detailed market report on ‘Global Durable Medical Equipment (DME) Market’ which includes the ongoing industry innovations and recent trends being adopted by the major industry players to achieve their business targets. Apart from that, the inclusive data on market size, growth rate, market revenue share, growth opportunities and challenges for the market players along with worldwide analysis on five major regions – North America, Latin America, Europe, Asia Pacific and Middle East & Africa has been provided in the report.

Healthcare expenditure has been improving in recent years and the healthcare expenditure as a part of the GDP escalated by 9.7% in all the OECD nations in 2020 which roughly rose by 8.8% back in 2019. The global durable medical equipment (DME) market is estimated to garner around USD 270 billion in revenue by 2031 by growing at a CAGR of nearly 6% over the forecast period, i.e., 2022 – 2031.

The growth of the market can majorly be attributed to the growing geriatric population, and the rising demand for home healthcare services on the back of increasing patients’ preference of availing post-operative and long-term care at home. Additionally, increasing demand pertaining to rent durable medical equipment, and the utility of durable medical equipment for diverse aspects, such as BP monitoring, blood glucose analysers, nebulizers, and many others are further expected to boost the market growth. It was noted that, the annual prevalence of renting two or more durable medical equipment categories increased by 300% between 2008 and 2018 across the globe.

Get a Sample PDF of This Report @ https://www.kennethresearch.com/sample-request-10070523

Furthermore, increasing disposable income per capita, and technological advancements in durable medical equipment products are also predicted to boost the global durable medical equipment (DME) market growth during the forecast period. For instance, in 2020, the global disposable income per capita was USD 8,784. Moreover, rising number of insurance companies across the globe, and their growing percentage in commercial service exports and imports are anticipated to be other important factors to drive the growth of the global durable medical equipment (DME) market. According to the data by The World Bank, in 2021, insurance and financial services accounted to 11% in global commercial service exports and 10% in global commercial service imports. Also, market participants are investing substantially in portfolio extensions. The most advanced ultrasound device till date from GE Healthcare was launched as the ‘Voluson Expert 22’. This most recent addition to the Women's Health portfolio of GE Healthcare generates images of high quality and resolution with lesser processing time that provides more flexibility for imaging activities.

Browse to access In-depth research report on Global Durable Medical Equipment (DME) Market with detailed charts and figures: https://www.kennethresearch.com/report-details/durable-medical-equipment-dme-market/10070523

Regionally, the global durable medical equipment (DME) market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market in North America region is estimated to witness significant growth over the forecast period. This growth can be accredited to increasing chronic diseases, growing adoption for home-based monitoring devices, and increased manufacturing of critical medical equipment in the region.

According to the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), six in ten Americans live with at least one chronic disease, such as, heart disease and stroke, cancer, or diabetes. These and other chronic diseases are the leading causes of death and disability in America, and they are a leading driver of health care costs as well. Furthermore, high adoption of technologically advanced products in the region, increasing healthcare expenditure  per capita, growing number of insurance companies throughout the region, and growing R&D activities to develop products that improve patient comfort by companies in the region are also propelling the growth of the market in the North America region. In November 2021, a novel blood sugar monitor, POGO Automatic Blood Glucose Monitoring System by Intuity Medical was launched in the US that allows easy button-push enabled blood test, unlike conventional test strip insertion or finger sticking methods. The product is FDA approved and is suitable for diabetic patients who are 13 years of age and above.

Get a Sample PDF of Global Durable Medical Equipment (DME) Market @ https://www.kennethresearch.com/sample-request-10070523

On the other hand, the Asia Pacific region is expected to grow at the highest CAGR during the forecast period for durable medical equipment market on the back unbalanced diet patterns that lead to several complications such as lifestyle disorders and infections. Also, growing elderly population, and improved healthcare facilities are also helping durable medical equipment sector boom. According to the Asian Development Bank, the number of elderly persons in the Asia Pacific region will reach 1.3 billion by 2050 which means, one in four persons will be older than 60 for the given period. Restricted mobility among the elderly population has necessitated adoption of personal mobility devices and this has also lent growth impetus to the durable medical equipment market in the region. China is witnessing a rise in medical device adoption and holds approximately over 22% of the total market globally. Optimistic growth in the country is supported by a fast increasing geriatric population and improved care centers for the elderly, besides several others. Hence, these factors are predicted to boost the demand for durable medical equipment in the projected years and estimated to be significant factors to fuel the market growth in the Asia Pacific region.

The study further incorporates Y-O-Y growth, demand & supply and forecast future opportunity in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).

Access full Report Description, TOC, Table of Figure, Chart, etc. @ https://www.kennethresearch.com/sample-request-10070523

The global durable medical equipment (DME) market is segmented on the basis of device into personal mobility devices, medical furniture, bathroom safety devices, monitoring and therapeutic devices, and others. Out of these, the personal mobility devices segment is anticipated to hold the hold the major share during the forecast era. The growth of this segment can be majorly accredited to the frequent launch of technologically more advanced products with improved comfort and portability. For instance, as of now, there are approximately 2 million different kinds of medical devices on the world market, categorized into more than 7000 generic devices groups.

Furthermore, the global durable medical equipment (DME) market is segmented based on end user into hospitals, clinics, home health care, and ambulatory surgical centers, and others. Out of these, the hospitals segment is anticipated to hold a substantial market share over the forecast period on the back of increasing awareness in healthcare, increasing diagnosis rate, which results in increasing hospital admissions, and increasing health expenditure per capita among the global population. According to The World Bank, as of 2019, current health expenditure per capita among the global population was USD 1,121.97.

Enquiry before Buying This Report @ https://www.kennethresearch.com/sample-request-10070523

Some of the prominent players and their company profiling mentioned in the report include Stryker, NIHON KOHDEN CORPORATION, General Electric Company, GF Health Products, Inc., Medtronic, Getinge AB, Compass Health Brands, Dun & Bradstreet, Inc., Koninklijke Philips N.V., Medical Device Depot, Inc., and others. This profiling enfolds growth opportunities, challenges, market trends, competitive analysis and positioning, along with the strategies used by them to stay ahead of their competitors.

Anal Fissure Treatment Market Analysis by Treatment Type (Laxatives, Calcium Channel Blocking Drugs, Nitroglycerin, Stool Softeners, Botulinum Toxin A, Surgery, and Others); by Route of Administration (Topical, and Oral); by End-Users (Hospitals, Clinics, Academic & Research Institutes, Homecare, Specialty Clinics, and Others); and by Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy)-Global Supply & Demand Analysis & Opportunity Outlook 2022- 2031

Therapeutic Guidewire Market Analysis by Type (Solid Guidewire, and Wrapped Guidewire); by Shape (J-Shaped, Angled, and Straight); by Application (Neurovascular Diseases, Peripheral Artery Disease, and Others); and by End-User (Hospitals, Academic Institutes, and Clinics)-Global Supply & Demand Analysis & Opportunity Outlook 2022-2031

Injectable Drug Delivery Devices Market Analysis by Product Type (Conventional, and Self-Injection Devices); by End Users (Hospital, Homecare, Clinics, and Others); and by Application (Curative Pattern, and Immunization)-Global Supply & Demand Analysis & Opportunity Outlook 2022-2031

Clinical Laboratory Services Market Analysis by Service Provider (Clinic-Based, Hospital-Based, and Independent Laboratories); and by Test Type (Hematology, Human & Tumor Genetics, Cytology, Immunology, and Others)-Global Supply & Demand Analysis & Opportunity Outlook 2022-2031

Serum Separation Gels Market Analysis by Application (Pharmaceutical Companies, Hospital & Clinics, Blood Bank, and Others); and by Product Type (Serum Separation Gel Without Integrated Tubes, and Serum Separation Gel with Integrated Tubes)-Global Supply & Demand Analysis & Opportunity Outlook 2022-2031

Kenneth Research is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

Web: https://www.kennethresearch.com/

The entrepreneur Mark Cuban just took a stand in a debate that's hotly controversial in business circles and Congress.

SNDL Inc. (NASDAQ: SNDL) ("SNDL" or the "Company") reported its financial and operational results for the second quarter ended June 30, 2022. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. All results for the second quarter of 2021 exclude the subsequent acquisitions of Inner Spirit Holdings ("Spiritleaf") and Alcanna Inc. ("Alcanna"), which closed on July 20, 2021, and March 31, 2022, respectively.

Inflation is still near multi-decade highs. Mr. Wonderful is using these stocks to fight back.

These are the top trending tickers on Yahoo Finance after-hours on Aug. 12.

Three state-owned Chinese corporate giants announced plans Friday to remove their shares from the New York Stock Exchange, adding to a growing financial separation between the biggest global economies in the midst of a dispute over scrutiny of company audits.

In this article, we talk about 11 best falling stocks to buy now. If you wish to skip our detailed analysis of the latest market situation, go directly to 5 Best Falling Stocks To Buy Now. After a brutal 2022 which saw the S&P500 shed more than 21% in the first half of the year, Q2 […]

Inflation has been making headlines all year, and rightly so; it’s at 40-year high levels, driven by sharp increases in the prices of gasoline and diesel fuels. But oil and its various refined products have come down in recent weeks, and so – the July inflation numbers weren’t as bad as had been feared. The overall year-over-year price increase for the month came to 8.5%, still awful, but less than the 8.7% economists had been predicting. Markets these days are rallying in response. Whether this

Tesla has given investors something to look forward to this coming week: a three-for-one stock split. As of the close of trading on Aug. 24, Tesla shareholders will get a “dividend” of two extra shares. The next day, Tesla stock will start trading at the new price—a third of what it used to be.

The super investor sees softness. But is sticking to her guns.

Profit warnings from Nvidia and Micron have sent a chill through chip stocks, but the long-term opportunity is still intact.

Johnson & Johnson stock is hitting its lowest level since March. Here's where it's a steal of a deal.

(Bloomberg) -- Principal Global Investors’ Seema Shah is no stock market bull but says the rally that erupted Wednesday may continue until the head of the Federal Reserve steps up and stops it.Most Read from BloombergStriking Drop in Stress Hormone Predicts Long Covid in StudyThe Fed’s Damage to the Housing Market May Last YearsGarland Seeks to Unseal Trump Warrant, Says He Approved SearchChina Has Painted Itself Into a Semiconductor CornerRuto, Odinga Shy of Victory in Latest Vote Counts: Kenya

Most of the handful of Wall Street analysts covering Berkshire are neutral on the stock, but they may be giving Warren Buffett insufficient credit.

The board of Devon Energy Corporation ( NYSE:DVN ) has announced that it will be paying its dividend of $1.55 on the...

The S&P 500’s initial surge on Thursday to fresh three-month highs fizzled as the session wore on. The good news for bulls is that this is a Tom Jones rally, as in his famous song: “It’s not unusual.” Specifically, there is nothing superlative about the market’s, notably the Nasdaq’s, resurgence off its mid-June trough, suggests Bespoke Investment Group.

Yahoo Finance Live looks at several Chinese stocks reportedly scheduled to de-list from the NYSE.

Billionaire investor George Soros’s investment fund has bought stakes in Tesla Inc. and Ford Motor Co. and added to existing stakes in Lucid Group Inc. and Nio Inc., according to a filing late Friday.

After a 3.3% weekly gain, the S&P 500 is down just 10% for the year. Stocks could keep rising if the Fed shows restraint from here.

Julie Biel, Kayne Anderson Rudnick Portfolio Manager and Senior Research Analyst, and Kevin Nicholson, RiverFront Investment Group Global Fixed Income CIO, sit down with Yahoo Finance Live to talk about inflation's impact on consumers, market rally trends, the outlook of the travel industry, and defensive sectors.

Guggenheim Partners analyst John DiFucci launched coverage of the group late Thursday, with some thoughts on where to place bets in the sector. DiFucci is new to Guggenheim, but a familiar name on the Street—at various times, he’s covered the software sector for Jefferies, J.P Morgan, Oppenheimer, and a couple of place that have since disappeared—Bear Stearns and Donaldson, Lufkin & Jenrette. DiFucci has Buy ratings on Oracle (ORCL), Palo Alto Networks (PANW), CrowdStrike (CRWD), Splunk (SPLK), Zscaler (ZS), and Progress Software (PRGS).